C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis

Atherosclerosis
Sandra A SchreyerR C LeBoeuf

Abstract

Non-insulin-dependent diabetes mellitus (NIDDM) is a major risk factor for the development of atherosclerosis in humans. The development of an animal model that displays accelerated atherosclerosis associated with NIDDM will aid in elucidating the mechanisms that associate these disorders. C57BL/6 mice may provide such a model system. This strain becomes obese, hyperglycemic and insulin resistant when fed a high fat diet (diabetogenic diet) and is susceptible to atherosclerotic lesion development when fed a separate high fat diet containing cholesterol and bile acids (atherogenic diet). This report tests whether a diet commonly used to induce atherosclerosis also provokes a diabetic phenotype and whether a diet used to induce diabetes provokes the development of aortic fatty streak lesions. Mice of strains C57BL/6, C3H/He, BALB/c and seven recombinant inbred (RI) strains were fed an atherogenic diet for 14 weeks and glucose parameters were measured. No correlation was observed between atherosclerosis susceptibility and fasting insulin or glucose levels, or glucose clearance following short-term insulin or glucose treatment. Analysis of the RI strains suggested that multiple genes control these glucose metabolic parameters. Feed...Continue Reading

References

Mar 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·B PaigenD Albee
Sep 1, 1988·Diabetes·R S SurwitM N Feinglos
Dec 1, 1987·Atherosclerosis·B PaigenR A Williams
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·B PaigenR C LeBoeuf
Jan 1, 1986·Methods in Enzymology·A J Lusis, R C LeBoeuf
May 1, 1995·Metabolism: Clinical and Experimental·R S SurwitM Rebuffé-Scrive
Sep 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J H QiaoA J Lusis
May 1, 1994·Metabolism: Clinical and Experimental·P M NishinaB Paigen
Apr 1, 1996·The Journal of Clinical Investigation·V V KunjathoorR C LeBoeuf

❮ Previous
Next ❯

Citations

Apr 9, 2008·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Marie-France ChampyJohan Auwerx
Jan 8, 2004·Atherosclerosis·Ira J GoldbergLi Shin Huang
Oct 21, 2009·The British Journal of Nutrition·Kristina E AnderssonPer Hellstrand
Feb 26, 2013·The British Journal of Nutrition·Marianne A YonLucy C Pickavance
Jan 31, 2012·Journal of Natural Products·Sio-Hong LamShoei-Sheng Lee
Apr 12, 2003·Clinical and Experimental Pharmacology & Physiology·Sharyn M FitzgeraldGöran Bergström
Feb 14, 2009·Pancreas·Caroline Fernandes-SantosCarlos Alberto Mandarim-de-Lacerda
Sep 11, 2008·American Journal of Physiology. Endocrinology and Metabolism·Craig S NunemakerJerry L Nadler
Jul 14, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Sherma ZibadiRonald R Watson
Apr 18, 2001·The Journal of Clinical Investigation·K TordjmanC F Semenkovich
Nov 26, 2008·BMC Biochemistry·Simon S Wing
Feb 19, 2013·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Michael S DoddDamian J Tyler
Oct 27, 2009·Molecular Neurodegeneration·Sonia FranciosiGregory A Elder
Jul 29, 2010·Journal of Clinical Biochemistry and Nutrition·Soo Mi KimMi Young Kang
Jun 21, 2014·PloS One·Xiujing FengZhenghe Wang
Sep 26, 2013·Antioxidants & Redox Signaling·Yong WuXuan Liu
Jul 12, 2013·Journal of Diabetes Research·Li-Li KongLi-Ning Miao
Jun 6, 2013·BioMed Research International·Charlotte AndersenJohn Nielsen
Oct 19, 2011·Journal of Lipids·Lindsey R BooneGene C Ness
Jun 6, 2009·The Journal of Physiology·Sharon E MitchellLynda M Williams
Oct 2, 2004·Kidney International·Anja S MühlfeldCharles E Alpers
Jul 11, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Yi-Chun WengMing-Jai Su
Feb 24, 2009·Diabetes Research and Clinical Practice·Melissa HenryLeslie S Ritter
Mar 9, 2006·Diabetes & Metabolism·C Renard, E Van Obberghen
Nov 23, 2006·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·James C Russell, Spencer D Proctor
May 4, 2011·Journal of Food Science·Myoung Jin SonMi Young Kang
Sep 19, 2006·Atherosclerosis·Kenneth K Wu, Youming Huan
Apr 12, 2005·Advances in Chronic Kidney Disease·Matthew D BreyerKumar Sharma
Aug 18, 2004·International Journal of Experimental Pathology·Shoumin XiQiuju Zhang
Mar 6, 2009·European Journal of Clinical Investigation·E D BartelsL B Nielsen
May 3, 2013·Clinical Science·Karen E Porter, Kirsten Riches

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.